Johns Hopkins Medicine

Alzheimer's Disease Research Center

Dean Wong, M.D.

Dr. Wong Photo

Associated Investigator


  • Wong DF, Comley R, Kuwabara H, Rosenberg P, Resnick S, Ostrowski S, Vozzi C, Boess F, Oh E, Lyketsos C, Honer M, Gobbi L, Klein G, George N, Gapasin L, Kitzmiller K, Roberts J, Sevigny J, Nandi A, Brasic J, Mishra C, Thambisetty M, Moghekar A, Mathur A, Albert M, Dannals R, Borroni E. First in-human PET study of 3 novel tau radiopharmaceuticals: [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948. J Nucl Med. 2018 [Epub ahead of print]
  • Tian Q, Resnick S, Bilgel M, Wong DF, Ferrucci L, Studenski S. Beta amyloid burden predicts lower extremity performance decline in cognitively unimpaired older adutls. J Gerontol A Bio Sci Med Sci 2017; 72: 716-723.
  • Leinonen V, Rinne JO, Wong DF, Wolk DA, Trojanowski JQ, Sherwin PF, Smith A, Heurling K, Su M, Grachev ID. Diagnostic effectiveness of [18F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard truth in subjects with idiopathic normal pressure hydrocephalus. Acta Neuropathol Commun 2014; 2: 46.
  • Wong DF, Moghekar AR, Rigamonti D, Brasic JR, Rousset O, Willis W, Buckley C, Smith A, Gok B, Sherwin P, Grachev ID. An in vivo evaluation of cerebral cortical amyloid with [18F] flutemetamol using positron emission tomography compared with parietal biopsy samples in living normal pressure hydrocephalus patients. Mol Imaging Biol. 2013; 15: 230-237.


Primary Appointment in Radiology
Radiology Joint, Psychiatry and Behavioral Sciences